Phosphatidylinositol-dependent Protein Kinase PTPN12: A Promising Drug Target

Target Name: PTPN12

NCBI ID: G5782

PTPN12

Phosphatidylinositol-dependent Protein Kinase PTPN12: A Promising Drug Target

Protein-tyrosine phosphatase G1 (PTPN12) is a protein that is expressed in various tissues throughout the body. It is a key enzyme in the phosphatidylinositol (PI) signaling pathway, which is involved in a variety of cellular processes, including cell signaling, protein synthesis, and storage. PTPN12 is also known as protein-tyrosine phosphatase G1, and its official name is Glycophosphorylase G1.

The PI signaling pathway is a complex series of reactions that involve the phosphorylation and dephosphorylation of different protein substrates. The pathway is composed of several different enzymes, including PTPN12, which is involved in the dephosphorylation of the protein known as PIP2. PIP2 is a key protein involved in cell signaling, and it is often used as a drug target or biomarker.

PTPN12 is a protein that is often targeted by drugs because of its role in the PI signaling pathway. Its activity as a phosphatidylinositol-dependent protein kinase (PKA) has been identified as a potential therapeutic target for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

One of the key advantages of PTPN12 as a drug target is its expression in various tissues. It is found in the brain, heart, liver, and kidneys, which makes it a potential target for drugs that can affect it without causing harm to other tissues. Additionally, its activity as a PKA kinase suggests that it may be involved in a wide range of cellular processes, which makes it an attractive target for drugs that can modulate its activity.

PTPN12 has also been shown to be involved in the regulation of various cellular processes. For example, it has been shown to be involved in the regulation of cell adhesion, migration, and invasion. It has also been shown to play a role in the regulation of cell survival and apoptosis.

In addition to its involvement in the PI signaling pathway, PTPN12 has also been shown to be involved in the regulation of other signaling pathways. For example, it has been shown to be involved in the regulation of the TGF-β pathway, which is involved in cell growth, differentiation, and survival. It has also been shown to be involved in the regulation of the Wnt pathway, which is involved in the regulation of cell growth and differentiation.

Despite its potential as a drug target, PTPN12 is not yet widely studied. There are currently few studies that have focused specifically on its role in the PI signaling pathway and its potential therapeutic applications. As research continues, however, it is likely that PTPN12 will become a valuable tool for the development of new treatments for a wide range of diseases.

Protein Name: Protein Tyrosine Phosphatase Non-receptor Type 12

Functions: Dephosphorylates a range of proteins, and thereby regulates cellular signaling cascades (PubMed:18559503). Dephosphorylates cellular tyrosine kinases, such as ERBB2 and PTK2B/PYK2, and thereby regulates signaling via ERBB2 and PTK2B/PYK2 (PubMed:17329398, PubMed:27134172). Selectively dephosphorylates ERBB2 phosphorylated at 'Tyr-1112', 'Tyr-1196', and/or 'Tyr-1248' (PubMed:27134172)

The "PTPN12 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PTPN12 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets